Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors

NCT01049841 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Solid Tumors

Interventions

DRUG: perifosine + temsirolimus

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]